Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorderActive, not recruitingPhase 1 / Phase 22026-06-02NCT05092347

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Regeneron Pharmaceuticals238

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Cedars-Sinai Medical CenterLos AngelesUnited States392
Comprehensive Transplant CenterChicagoUnited States2
Connie Frank Transplant Center at UCSFSan FranciscoUnited States3
John Hopkins HospitalBaltimoreUnited States2
Medstar Georgetown Transplant Institute - 2-PHCWashington D.C.United States1
New York University Langone HealthNew YorkUnited States18
Penn Transplant InstitutePhiladelphiaUnited States2
University of California IrvineOrangeUnited States49
University of MinnesotaMinneapolisUnited States325
Yale University of MedicineNew HavenUnited States2